Philip Morris International Inc. Presents at the Consumer Analyst Group of New York (CAGNY) Conference
19 2월 2015 - 3:35AM
Business Wire
Regulatory News:
Philip Morris International Inc.’s (NYSE / Paris Euronext: PM)
Chief Financial Officer, Jacek Olczak, addresses investors today at
the CAGNY Conference in Boca Raton, Florida.
The presentation and Q&A session are being webcast live, in
a listen-only mode, beginning at approximately 1:45 p.m. ET, at
www.pmi.com/webcasts. An archived copy of the webcast, together
with presentation remarks and slides, will be available on the same
site. The presentation will include an overview of the Company’s:
2014 results and expectations for 2015; currency exposure and
strategies to mitigate its impact; superior brand portfolio, its
performance and outlook; exciting prospects for its Reduced-Risk
Products*, including the launch of its new e-vapor product,
Solaris; focus on managing cash flow prudently, notably through the
judicious management of working capital and capital expenditures;
and commitment to returning cash to shareholders.
PMI also reaffirms its guidance, announced on February 5, for
2015 full-year reported diluted earnings per share to be in a range
of $4.27 to $4.37, at prevailing exchange rates at that time,
versus $4.76 in 2014. Excluding an unfavorable currency impact, at
then prevailing rates, of approximately $1.15 per share for the
full-year 2015, the reported diluted earnings per share range
represents an increase of 8% to 10% versus adjusted diluted
earnings per share of $5.02 in 2014. This guidance includes
incremental spending versus 2014 for our Reduced-Risk Product,
iQOS, and does not include any share repurchases in 2015.
Adjusted diluted earnings per share of $5.02 in 2014 are
calculated as reported diluted earnings per share of $4.76, plus a
$0.26 per share charge related to asset impairment and exit
costs.
This 2015 guidance excludes the impact of future acquisitions,
unanticipated asset impairment and exit cost charges, future
changes in currency exchange rates and any unusual events.
The presentation, related discussion and this release contain
statements that, to the extent they do not relate strictly to
historical or current facts, constitute "forward-looking
statements" within the meaning of the Safe Harbor Provisions of the
Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are based on current plans, estimates
and expectations, and are not guarantees of future performance.
They are based on management's expectations that involve a number
of business risks and uncertainties, any of which could cause
actual results to differ materially from those expressed in or
implied by the forward-looking statements.
The risks and uncertainties relating to the forward-looking
statements in the presentation, related discussion and this release
include those described under Item 1A. “Risk Factors” in PMI’s Form
10-Q for the quarter ended September 30, 2014, filed with the
Securities and Exchange Commission. PMI does not undertake to
publicly update or revise any forward-looking statements, except in
the normal course of its public disclosure obligations.
About Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the leading
international tobacco company, with seven of the world’s top 15
international brands, including Marlboro, the number one cigarette
brand worldwide. PMI’s products are sold in more than 180 markets.
In 2014, the company held an estimated 15.6% share of the total
international cigarette market outside of the U.S., or 28.6%
excluding the People’s Republic of China and the U.S. For more
information, see www.pmi.com.
* Reduced-Risk Products (“RRPs”) is the term the company uses to
refer to products with the potential to reduce individual risk and
population harm in comparison to smoking combustible cigarettes.
PMI’s RRPs are in various stages of development, and we are
conducting extensive and rigorous scientific studies to determine
whether we can support claims for such products of reduced exposure
to harmful and potentially harmful constituents in smoke, and
ultimately claims of reduced disease risk, when compared to smoking
combustible cigarettes. Before making any such claims, we will need
to evaluate rigorously the full set of data from the relevant
scientific studies to determine whether they substantiate reduced
exposure or risk. Any such claims may also be subject to government
review and approval, as is the case in the U.S. today.
Philip Morris International Inc.Investor RelationsNew
York: +1-917-663-2233Lausanne: +41 (0)58 242
4666orMedia:Lausanne: +41 (0)58 242 4500
P M I (NYSE:PMI)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
P M I (NYSE:PMI)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024